High-level adenovirus-neutralizing antibodies plasma beneficial for adenovirus type 7 (Adv7) induced pediatric severe ARDS
HL-ANAP may be effective in treating ARDS induced by severe type-7 adenoviral pneumonia in children. This approach may reduce adenovirus load, decrease systemic inflammation, and improve clinical outcomes. The neutralizing antibody's activity against the virus may occur within 24-72 hours post-infusion in vivo.
Authors
- Feiyan Chen (ORCID: https://orcid.org/0000-0003-3730-1651)
- Mingqi Zhao (ORCID: https://orcid.org/0000-0002-2804-9565)
- Jinda Huang (ORCID: https://orcid.org/0000-0003-3177-8993)
- Yi Chen (ORCID: https://orcid.org/0000-0002-9626-9869)
- Yiyu Yang (ORCID: https://orcid.org/0000-0003-4796-9268)
- Yunlong Zuo
- Run Dang (ORCID: https://orcid.org/0009-0003-2764-3540)
Institutions
- Guangzhou Women and Children Medical Center (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Journal of Virus Eradication
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1016/j.jve.2025.100595
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00